Cannabis Lending Expansion Will Unlock Opportunities Amid Credit Risks

Published
25 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$17.63
20.7% undervalued intrinsic discount
14 Aug
US$13.98
Loading
1Y
-9.7%
7D
1.6%

Author's Valuation

US$17.6

20.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 5.10%

Shared on23 Apr 25
Fair value Decreased 6.42%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.1% to 0.1%.

Shared on17 Apr 25
Fair value Increased 2.28%

AnalystConsensusTarget has decreased revenue growth from 4.6% to 3.7%.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.92%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 2.47%

AnalystConsensusTarget has increased revenue growth from 2.1% to 4.6%, decreased profit margin from 73.1% to 65.1% and increased future PE multiple from 10.3x to 12.7x.

Shared on11 Mar 25
Fair value Decreased 4.11%